Biosimilars: Fact vs Fiction
Understanding biosimilars and their potential for lowering cancer care costs.
On Wednesday, September 25th, 2019 at 11 am ET join us for Biosimilars: Fact vs Fiction!
About this Webinar
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers and providers. In this webinar, NantHealth and a panel of respected medical experts examine:
- The true definition of biosimilars and their potential in cancer care
- The opportunities to drive down costs
- Common misconceptions and concerns about safety and efficacy
- Issues around payer reimbursement and provider incentives
- The role of technology in navigating biosimilars